Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: A prospective study

被引:35
作者
Andrews, L [1 ]
Meiser, B
Apicella, C
Tucker, K
机构
[1] Prince Wales Hosp, Hereditary Canc Clin, Randwick, NSW 2031, Australia
[2] Ctr Genet Epidemiol, Carlton, Vic 3053, Australia
来源
GENETIC TESTING | 2004年 / 8卷 / 03期
关键词
D O I
10.1089/gte.2004.8.240
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The recognition that the prevalence of three founder mutations in the BRCA1 and BRCA2 genes is over 2% in Ashkenazi Jews has resulted in numerous epidemiological research studies of this ethno-religious group. To determine the effects of incorporating research into clinical practice, a psychological impact study of women participating in an epidemiological study was conducted. Sixty women of Ashkenazi Jewish background who underwent genetic testing for founder mutations were assessed using mailed, self-administered questionnaires with validated measures of psychological outcome. Forty-three women elected to learn their results and 17 women declined to do so. Women who elected to learn their results were also assessed 7-10 days, 4 months, and 12 months after results disclosure. Women who chose to learn their results had significantly higher baseline breast cancer anxiety, compared to those who elected not to learn their results (z = -2.27; p = 0.023). Unaffected women who elected to learn their results showed a significant decrease in breast cancer anxiety 4 months (z = -2.37, p = 0.018) and 12 months (z = -3.06, p = 0.002) post-notification compared to baseline. Genetic testing for mutations common in Ashkenazi Jewish women with result disclosure does not lead to adverse psychological outcomes.
引用
收藏
页码:240 / 247
页数:8
相关论文
共 36 条
[1]  
Abeliovich D, 1997, AM J HUM GENET, V60, P505
[2]   Interest in learning of personal genetic risk for cancer: A general population survey [J].
Andrykowski, MA ;
Munn, RK ;
Studts, JL .
PREVENTIVE MEDICINE, 1996, 25 (05) :527-536
[3]  
Bahar AY, 2001, CANCER-AM CANCER SOC, V92, P440, DOI 10.1002/1097-0142(20010715)92:2<440::AID-CNCR1340>3.0.CO
[4]  
2-O
[5]   Transmission of response to trauma? Second-generation Holocaust survivors' reaction to cancer [J].
Baider, L ;
Peretz, T ;
Hadani, PE ;
Perry, S ;
Avramov, R ;
De-Nour, AK .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (06) :904-910
[6]  
Beck A.T., 1993, BECK DEPRESSION INVE
[7]  
BENJAMIN B, 1996, NAT GENET, V14, P185
[8]   Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history [J].
Berry, DA ;
Parmigiani, G ;
Sanchez, J ;
Schildkraut, J ;
Winer, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (03) :227-238
[9]   Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer [J].
FitzGerald, MG ;
MacDonald, DJ ;
Krainer, M ;
Hoover, I ;
ONeil, E ;
Unsal, H ;
SilvaArrieto, S ;
Finkelstein, DM ;
BeerRomero, P ;
Englert, C ;
Sgroi, DC ;
Smith, BL ;
Younger, JW ;
Garber, JE ;
Duda, RB ;
Mayzel, KA ;
Isselbacher, KJ ;
Friend, SH ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :143-149
[10]  
Friedman LC, 1999, GENET MED, V1, P74